Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market
Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market
Launch of Novel Oral Therapies to Result in Major Market Changes
RELEASE DATE
20-Nov-2014
20-Nov-2014
REGION
North America
North America
Research Code: NED2-01-00-00-00
SKU: LS00131-NA-MR_16972
$3,950.00
In stock
SKU
LS00131-NA-MR_16972
Description
This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.
Table of Contents
Key Findings
Key Findings (continued)
Companies to Watch
Defining Healthcare Trends in the Future
Executive Summary—CEO’s Perspective
Market Overview—Definitions
Market Overview—Definitions (continued)
Market Overview—Definitions (continued)
Market Overview—Definitions (continued)
Market Overview—Definitions (continued)
Market Overview—Definitions (continued)
Market Overview—Segmentation
Market Overview—Segmentation (continued)
Market Overview—Segmentation (continued)
Rheumatoid Arthritis Global Incidence
Drivers and Restraints
Competitive Factors and Assessment
Competitive Landscape—Count of Marketed and Pipeline Products
Competitive Landscape—Marketed and Pipeline Products
Marketed Product Analysis
Marketed Product Analysis (continued)
Patent Expiration Timeline
Pipeline Analysis—Products in Clinical Development
Pipeline Analysis—Products in Clinical Development (continued)
Pipeline Analysis—Products in Clinical Development (continued)
Product Launch Timeline
Phase 3 Clinical Program—Next Product Launches
Product Dashboard—Eli Lilly’s Baricitinib
Product Dashboard—Sanofi/Regeneron’s SAR153191/REGN88
Product Dashboard—Biocad’s BCD-020
The Last Word—Three Big Predictions
The Last Word—Discussion
Legal Disclaimer
Market Engineering Methodology
Table of Acronyms Used
Table of Acronyms Used (continued)
Table of Acronyms Used (continued)
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Additional Sources of Information on Rheumatoid Arthritis
Additional Sources of Information on Rheumatoid Arthritis (continued)
Learn More—Next Steps
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Related Research
Popular Topics
electric vehicle market analysis
residential energy storage market
This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.
No Index | No |
---|---|
Podcast | No |
Author | Lucila Rocca |
WIP Number | NED2-01-00-00-00 |
Is Prebook | No |